ELEVATED TUMOR-INFILTRATING LYMPHOCYTES

Clinical trials for ELEVATED TUMOR-INFILTRATING LYMPHOCYTES explained in plain language.

Never miss a new study

Get alerted when new ELEVATED TUMOR-INFILTRATING LYMPHOCYTES trials appear

Sign up with your email to follow new studies for ELEVATED TUMOR-INFILTRATING LYMPHOCYTES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a biomarker spare breast cancer patients from harsh chemo?

Disease control Not yet recruiting

This trial explores whether people with early-stage triple-negative breast cancer and high levels of tumor-infiltrating lymphocytes (TILs) can safely skip a class of chemotherapy drugs called anthracyclines, which are effective but can harm the heart. Participants receive 12 week…

Matched conditions: ELEVATED TUMOR-INFILTRATING LYMPHOCYTES

Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control

Last updated Aug 05, 2026 00:00 UTC

ELEVATED TUMOR-INFILTRATING LYMPHOCYTES

Get alerted when new ELEVATED TUMOR-INFILTRATING LYMPHOCYTES trials appear

Can a biomarker spare breast cancer patients from harsh chemo?